Masculinizing hormones decrease the risk for breast cancer. Transgender men are at less risk for breast cancer than cisgender women.
However, unless they've had a mastectomy, it's recommended that transgender men continue to follow breast cancer screening recommendations for cisgender women in their age group.
Transgender men who take masculinizing hormones and have had a mastectomy do not need to continue having breast cancer screenings.